Eirini Palaka
Overview
Explore the profile of Eirini Palaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grandy S, Palaka E, Guzman N, Dunn A, Wittbrodt E, Finkelstein F
J Patient Exp
. 2022 Apr;
9:23743735221092629.
PMID: 35425851
Anemia in chronic kidney disease (CKD) is associated with reduced health-related quality of life and physical functioning. This study investigated knowledge and awareness of anemia in patients with CKD in...
2.
Grandy S, Jackson J, Moon R, Bluff D, Palaka E
Int J Clin Pract
. 2021 May;
75(8):e14326.
PMID: 33960068
Background: Chronic kidney disease patients have impaired health-related quality of life and an increased risk of hyperkalaemia. Aims: The objective was to evaluate the impact of hyperkalaemia on health-related quality...
3.
Hao C, Wittbrodt E, Palaka E, Guzman N, Dunn A, Grandy S
Int J Nephrol Renovasc Dis
. 2021 Mar;
14:53-64.
PMID: 33654421
Background: Anemia is a common complication of chronic kidney disease (CKD) that may reduce patients' health-related quality of life (HRQoL). This study explored the experience and knowledge of patients with...
4.
van Haalen H, Sloand J, Moon R, Palaka E, Milligan G, Allum A, et al.
Kidney Res Clin Pract
. 2020 Sep;
39(3):318-333.
PMID: 32958723
Background: We explored the association of anemia severity in patients with chronic kidney disease (CKD) and anemia treatment with work productivity in China. Methods: Cross-sectional survey data from Chinese physicians...
5.
Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O
Int J Nephrol
. 2020 Jul;
2020:7692376.
PMID: 32665863
Anaemia is a common consequence of chronic kidney disease (CKD); however, the risk factors for its development and its impact on outcomes have not been well synthesised. Therefore, we undertook...
6.
Palaka E, Grandy S, Darlington O, McEwan P, van Doornewaard A
Int J Clin Pract
. 2019 Sep;
74(1):e13421.
PMID: 31532067
Background And Objectives: Despite the growing body of evidence characterising the association between serum potassium levels and adverse clinical outcomes, a contemporary summary of available evidence is currently lacking. The...
7.
Adelborg K, Nicolaisen S, Hasvold P, Palaka E, Pedersen L, Thomsen R
PLoS One
. 2019 Jun;
14(6):e0218739.
PMID: 31226134
Understanding predictors and trajectories of increased potassium may inform testing and treatment of hyperkalemia. We examined predictors for repeated hyperkalemia among patients after first-time renin angiotensin system inhibitor (RASi) prescription,...
8.
Kim K, Thomsen R, Nicolaisen S, Hasvold L, Palaka E, Sorensen H
BMJ Open
. 2019 Apr;
9(4):e026465.
PMID: 30940761
Objectives: To investigate healthcare costs associated with hyperkalaemia (HK) among patients with chronic kidney disease (CKD), heart failure (HF) or diabetes. Design: Before-after cohort study of patients with HK and...
9.
Evans M, Palaka E, Furuland H, Bennett H, Linde C, Qin L, et al.
BMC Nephrol
. 2019 Feb;
20(1):31.
PMID: 30704421
Background: People with chronic kidney disease (CKD) are at an increased risk of developing hyperkalaemia due to their declining kidney function. In addition, these patients are often required to reduce...
10.
Linde C, Qin L, Bakhai A, Furuland H, Evans M, Ayoubkhani D, et al.
ESC Heart Fail
. 2019 Jan;
6(2):280-290.
PMID: 30629342
Aims: At present, the clinical burden of hypokalaemia and hyperkalaemia among European heart failure patients, and relationships between serum potassium and adverse clinical outcomes in this population, is not well...